Zhejiang Huakang Pharmaceutical Balance Sheet Health
Financial Health criteria checks 3/6
Zhejiang Huakang Pharmaceutical has a total shareholder equity of CN¥3.2B and total debt of CN¥2.1B, which brings its debt-to-equity ratio to 66.1%. Its total assets and total liabilities are CN¥6.2B and CN¥3.0B respectively. Zhejiang Huakang Pharmaceutical's EBIT is CN¥300.0M making its interest coverage ratio -84.5. It has cash and short-term investments of CN¥447.3M.
Key information
66.1%
Debt to equity ratio
CN¥2.08b
Debt
| Interest coverage ratio | -84.5x |
| Cash | CN¥447.30m |
| Equity | CN¥3.15b |
| Total liabilities | CN¥3.04b |
| Total assets | CN¥6.19b |
Recent financial health updates
No updates
Recent updates
Zhejiang Huakang Pharmaceutical's (SHSE:605077) Anemic Earnings Might Be Worse Than You Think
Nov 02
Zhejiang Huakang Pharmaceutical Co., Ltd.'s (SHSE:605077) Earnings Are Not Doing Enough For Some Investors
Oct 14Zhejiang Huakang Pharmaceutical (SHSE:605077) Will Want To Turn Around Its Return Trends
Sep 26Improved Earnings Required Before Zhejiang Huakang Pharmaceutical Co., Ltd. (SHSE:605077) Shares Find Their Feet
Jul 02Zhejiang Huakang Pharmaceutical (SHSE:605077) May Have Issues Allocating Its Capital
May 28We Think That There Are Some Issues For Zhejiang Huakang Pharmaceutical (SHSE:605077) Beyond Its Promising Earnings
May 02Financial Position Analysis
Short Term Liabilities: 605077's short term assets (CN¥2.3B) exceed its short term liabilities (CN¥1.2B).
Long Term Liabilities: 605077's short term assets (CN¥2.3B) exceed its long term liabilities (CN¥1.8B).
Debt to Equity History and Analysis
Debt Level: 605077's net debt to equity ratio (51.9%) is considered high.
Reducing Debt: 605077's debt to equity ratio has increased from 27.6% to 66.1% over the past 5 years.
Debt Coverage: 605077's debt is not well covered by operating cash flow (13.4%).
Interest Coverage: 605077 earns more interest than it pays, so coverage of interest payments is not a concern.